Julie Olsson Selected Research

Pulmonary Eosinophilia (Eosinophilic Pneumonia)

10/2016

Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Julie Olsson Research Topics

Disease

7	Asthma (Bronchial Asthma) 01/2019 - 08/2015
5	Inflammation (Inflammations) 09/2021 - 01/2014
2	Idiopathic Pulmonary Fibrosis 01/2021 - 01/2014
1	Injection Site Reaction 01/2024
1	Food Hypersensitivity (Food Allergy) 01/2024
1	Peanut Hypersensitivity (Peanut Allergy) 01/2024
1	Chronic Obstructive Pulmonary Disease (COPD) 09/2021
1	Eosinophilia 01/2018
1	Airway Obstruction (Choking) 10/2017
1	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 10/2016
1	Aplastic Anemia (Anemia, Hypoplastic) 10/2016

Drug/Important Bio-Agent (IBA)

7	lebrikizumabIBA 01/2021 - 08/2015
4	Biomarkers (Surrogate Marker)IBA 09/2021 - 10/2016
4	Monoclonal AntibodiesIBA 01/2021 - 10/2016
3	PeriostinIBA 01/2018 - 08/2015
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2018 - 08/2015
2	Interleukin-13IBA 01/2018 - 10/2017
1	anti-IgE antibodiesIBA 01/2024
1	Omalizumab (Xolair)FDA Link 01/2024
1	AllergensIBA 01/2024
1	lysophosphatidic acidIBA 09/2021
1	LipidsIBA 09/2021
1	pirfenidoneIBA 01/2021
1	InterleukinsIBA 01/2021
1	Carbon MonoxideIBA 01/2021
1	montelukast (Singulair)FDA Link 01/2018
1	Bronchodilator Agents (Bronchodilators)IBA 10/2016

Therapy/Procedure

4	Therapeutics 01/2021 - 01/2014
1	Immunotherapy 01/2024